Mahendra T. Bhati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mahendra T. Bhati has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Francis
Department of Psychiatry and Behavioral Science, Penn State Medical School, United States
1 shared publication - Brent R. Carr
Department of Psychiatry , University of Florida College of Medicine , Gainesville , FL , USA
1 shared publication Casey H Halpern
Department of Psychiatry and Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA
1 shared publication- Casey Harrison Halpern
University of Pennsylvania
1 shared publication - Daniel F. Maixner
Department of Psychiatry, University of Michigan, Ann Arbor, MI
1 shared publication - Eric D. Achtyes
Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine
1 shared publication
Latest Publications
- Open Access
- 4 March 2022
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 38 (3) , 159-164
National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive Therapy
Electroconvulsive therapy (ECT) is a highly therapeutic and cost-effective treatment for severe and/or treatment-resistant major depression. However, because of the varied clinical practices, there is a great deal of heterogeneity in how ECT is delivered and documented. This represents both an opportunity to study how differences in implementation influence clinical outcomes and a challenge for carrying out coordinated quality improvement and research efforts across multiple ECT centers. The National Network of Depression Centers, a consortium of 26+ US academic medical centers of excellence providing care for patients with mood disorders, formed a task group with the goals of promoting best clinical practices for the delivery of ECT and to facilitate large-scale, multisite quality improvement and research to advance more effective and safe use of this treatment modality. The National Network of Depression Centers Task Group on ECT set out to define best practices for harmonizing the clinical documentation of ECT across treatment centers to promote clinical interoperability and facilitate a nationwide collaboration that would enable multisite quality improvement and longitudinal research in real-world settings. This article reports on the work of this effort. It focuses on the use of ECT for major depressive disorder, which accounts for the majority of ECT referrals in most countries. However, most of the recommendations on clinical documentation proposed herein will be applicable to the use of ECT for any of its indications.
- 4 March 2022
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 38 (3) , 159-164
Open AccessNational Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive Therapy
Electroconvulsive therapy (ECT) is a highly therapeutic and cost-effective treatment for severe and/or treatment-resistant major depression. However, because of the varied clinical practices, there is a great deal of heterogeneity in how ECT is delivered and documented. This represents both an opportunity to study how differences in implementation influence clinical outcomes and a challenge for carrying out coordinated quality improvement and research efforts across multiple ECT centers. The National Network of Depression Centers, a consortium of 26+ US academic medical centers of excellence providing care for patients with mood disorders, formed a task group with the goals of promoting best clinical practices for the delivery of ECT and to facilitate large-scale, multisite quality improvement and research to advance more effective and safe use of this treatment modality. The National Network of Depression Centers Task Group on ECT set out to define best practices for harmonizing the clinical documentation of ECT across treatment centers to promote clinical interoperability and facilitate a nationwide collaboration that would enable multisite quality improvement and longitudinal research in real-world settings. This article reports on the work of this effort. It focuses on the use of ECT for major depressive disorder, which accounts for the majority of ECT referrals in most countries. However, most of the recommendations on clinical documentation proposed herein will be applicable to the use of ECT for any of its indications.
- Open Access
- 1 March 2020
- Published by Elsevier in Brain Stimulation
- Vol. 13 (2) , 430-432
Adjunctive repetitive transcranial magnetic stimulation delivers superior quality of life for focal epilepsy compared to anti-epileptic drugs: A meta-analytic utility prediction study
- 1 March 2020
- Published by Elsevier in Brain Stimulation
- Vol. 13 (2) , 430-432
Open AccessAdjunctive repetitive transcranial magnetic stimulation delivers superior quality of life for focal epilepsy compared to anti-epileptic drugs: A meta-analytic utility prediction study
- 1 November 2017
- Published by Elsevier in The Lancet Psychiatry
- Vol. 4 (11) , 820-821
Deciphering deep brain stimulation for depression
- 1 November 2017
- Published by Elsevier in The Lancet Psychiatry
- Vol. 4 (11) , 820-821
Deciphering deep brain stimulation for depression